Skip to content
SFB-Pharma

SFB-Pharma

  • Office
  • Contact
  • About Us
Scroll down to content

Posts

Posted on 7 January 20207 January 2020

Bienvenue dans – Welkom bij:

Bienvenidos en – Welcome to:

SFB-Pharma

If you want to reach me please send a message to:

Christine Laroche  claroche@sfb-pharma.com

Recent Posts

  • (no title)

Archives

  • January 2020

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

RSS Drugs.com – New Drug Approvals

  • U.S. FDA Approves ALK's Ragwitek (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use as Immunotherapy for Children and Adolescents With Short Ragweed Pollen-Induced Allergic Rhinitis With or Without Conjunctivitis
  • FDA Approves Opdivo (nivolumab) in Combination with Chemotherapy for Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma Regardless of PD-L1 Expression Status
  • FDA Approves Nextstellis (drospirenone and estetrol) Oral Contraceptive for Birth Control
  • U.S. FDA Grants Accelerated Approval to Trodelvy for the Treatment of Metastatic Urothelial Cancer

RSS Pharma Manufacturing News

  • Johnson & Johnson to resume Covid-19 vaccine roll-out in Europe after EMA review
  • Second indication of Sarclisa for relapsed multiple myeloma approved by EC
  • US clearance granted for AstraZeneca’s proposed acquisition of Alexion

SFB-Pharma Info

  • About Us
  • Contact
  • Office

RSS White papers and Web seminars

  • Fireside Chat with Tandem Health & Cisco Meraki
  • Massive Interoperability: High-Performance Data Sharing at Scale
  • The Prescription for a Superior Healthcare Network
  • The Actively Connected Physician: How CMS Mandated ADT Event Notifications Lead to Improved Patient Care
Proudly powered by WordPress
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok